[Patent foramen ovale: a benign anatomical variant that can become a disease].
Patent foramen ovale (PFO) is mostly considered a benign anatomical variant but in presence of a significant right to left shunt, it can represent the substrate for embolic disease as cryptogenetic stroke, decompression syndrome, myocardial infarction with normal coronary arteries, etc. A diffuse therapeutic option consists in the PFO transcatheter closure: a procedure with no dedicated guidelines. We retrospectively studied demographic characteristics, clinical remarks, indications and morphological findings in 143 patients who underwent percutaneous PFO closure in the Interventional Cardiology Unit of the Rovigo General Hospital between 2006 and 2009.